基本信息
views: 355
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Phillips’ distinguished awards include: Canada Council Killam Senior Research Scholar (1978-80) and E.W.R. Steacie Fellow, NSERC (1980-82). In 1986, he was elected a Fellow of the Royal Society of Canada and was also the recipient of an inaugural UBC Killam Research Prize. The Canadian Psychological Association honoured him in 1995 with the Donald O. Hebb Award for ‘Distinguished Contributions to Psychology as a Science.’ In 1996, the Canadian College of Neuropsychopharmacology awarded him with the inaugural prize for ‘Innovations in Neuropsychopharmacoloty’ (with H.C. Fibiger) and in 2009, with the Heinz Lehmann Award. In 2010, Dr. Phillips was elected a Fellow in the Canadian Academy of Health Sciences.
Dr. Phillips also played an important role in the evolution of the biotechnology industry in Canada, having been a Founding Director of QLT and serving as Secretary/Treasurer to its Board from 1982-92, and currently as a Founder and Member of the Board of Allon Therapeutics Inc. He has been elected as President (2012-14) of the Collegium Internationale Neuro-Psychopharmacologicum (CINP).
Research Interests
Papers共 196 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
NEUROPHARMACOLOGY (2024): 109849-109849
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIEno. 1 (2024): 5-9
EUROPEAN JOURNAL OF NEUROSCIENCEno. 6 (2024): 1067-1078
International journal of molecular sciencesno. 10 (2023): 8872-8872
Load More
Author Statistics
#Papers: 201
#Citation: 17229
H-Index: 60
G-Index: 129
Sociability: 6
Diversity: 4
Activity: 38
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn